Rapid detection of cardioactive bufalin toxicity using fluorescence polarization immunoassay for digitoxin

Therapeutic Drug Monitoring

Volumn 20, Issue 1, 1998, Pages 104-108

  Dasgupta, Amitava ^a,c   Datta, Pradip ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b Chiron Diagnostics   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Bufalin; Digitoxin; Fluorescence polarization

Indexed keywords

BUFALIN; DIGITOXIN; DIGOXIN; INOTROPIC AGENT;

ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS REACTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG INTOXICATION; DRUG STRUCTURE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; MICROPARTICLE ENZYME IMMUNOASSAY; NORMAL HUMAN; PRIORITY JOURNAL; TOXIN STRUCTURE;

ANIMALS; ANURA; BUFANOLIDES; CARDIOTONIC AGENTS; DIGITOXIN; DIGOXIN; DRUG INTERACTIONS; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS;

EID: 0031912071     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199802000-00019     Document Type: Article

References (17)

1. Bedford PCG. Toad venom toxicity and its clinical occurrence in small animals in the United Kingdom. Vet Rec 1974;94:613-4.
2. Palumbo NE, Perri S, Read G. Experimental induction and treatment of toad poisoning in the dog. J Am Vet Assoc 1975;167: 1000-5.
3. Hitt M, Ettinger DD. Toad toxicity. N Eng J Med 1986;314: 1517-8.
4. Chern MS, Ray CY, Wu D. Biological intoxication to digitalis like substances after ingestion of cooked toad soup. Am J Cardiol 1991; 67:443-4.
5. Flier JS. Ouabain like activity in toad skin and its implications for endogenous regulation of ion transport. Nature 1978;274:285-6.
6. Flier JS, Maratos-Flier E, Pallotta JA, McIsaac D. Endogenous digitalis-like activity in the plasma of toad bufo marinus. Nature 1979;279:341-3.
7. Barry TL, Petzinger G, Zito W. GC/MS comparison of the West Indian aphrodisiac "Love Stone" to the Chinese medication "Chan Su:" Bufotenine and related bufadienolides. J For Sci 1996;41:1068-73.
8. Flier J, Edward MW, Daly JW, Myers CW. Widespread occurrences in frogs and toad skins of skin compounds interacting with the ouabain site of Na, K-ATPase. Science 1980;208:505-6.
9. Brownlee AA, Johnson P, Mills IH. Actions of bufalin and cinobufotalin, two bufadienolides respectively more and less active than ouabain om ouabain binding and 86 Rb uptake by human erythrocytes. Clin Sci 1990;78:169-174.
10. Panesar NS. Bufalin and unidentified substances in traditional Chinese medicine cross react in commercial digoxin assay. Clin Chem 1992;38:2155-6.
11. Datta P, Kohn D, Leonard H. An immunoassay for digitoxin on the Ciba-Corning ACS: 180 automated chemiluminescene system. [abstract]. Clin Chem 1995;41:S115.
12. Valdes R, Graves SW. Protein binding of endogenous digoxin-like immunoreactive factors in human serum and its variation with clinical condition. J Clin Endocrinol Metab 1985;60:1135-43.
13. Soldin SJ. Digoxin issues and controversies. Clin Chem 1986;32: 5-12.
14. Matheke ML, Valdes R. Antibody specificity reduces interference by endogenous digoxin-like immunoreactive factors. J Clin Immunoassay 1989;12:115-21.
15. Jortani SA, Miller JJ, Helm RA, Valdes R. Unexpected suppression of digoxin values caused by DLIF.1 [abstract]. Clin Chem 1996;42:S124.
16. Jortani SA, Helm RA, Valdes R. Inhibition of Na, K-ATPase by oleandrin and oleandrigenin and their detection by digoxin immunoassays. Clin Chem 1996;42:1654-8.
17. Miller JJ, Valdes R. Methods for calculating crossreactivity in immunoassays. J Clin Immunoassay 1992;15:97-107.